MoneyWorks4Me

A fair growth of 20.18% in the revenue at Rs. 1469.88 millions was reported in the September 2022 quarter as compared to Rs. 1223.08 millions during year-ago period.Profit saw a slight increase of 8.97%to Rs. 190.38  millions from Rs. 174.71 millions.Operating Profit saw a handsome growth to 289.79 millions from 275.34 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1469.88 1223.08 20.18 2779.94 2354.38 18.08 5201.35 3406.08 52.71
Other Income 8.54 1.63 423.93 14.73 11.95 23.26 27.62 13.30 107.67
PBIDT 289.79 275.34 5.25 525.21 506.57 3.68 1079.38 815.32 32.39
Interest 4.49 26.92 -83.32 6.31 54.81 -88.49 64.07 56.18 14.04
PBDT 285.30 248.42 14.85 518.90 451.76 14.86 1015.31 759.14 33.74
Depreciation 28.19 23.18 21.61 58.57 45.45 28.87 100.80 41.88 140.69
PBT 257.11 225.24 14.15 460.33 406.31 13.30 914.51 717.26 27.50
TAX 66.73 50.53 32.06 121.32 94.36 28.57 195.04 177.27 10.02
Deferred Tax 6.21 7.06 -12.04 10.84 10.29 5.34 27.83 1.63 1607.36
PAT 190.38 174.71 8.97 339.01 311.95 8.67 719.47 539.99 33.24
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 315.00 15.67
PBIDTM(%) 19.72 22.51 -12.42 18.89 21.52 -12.19 20.75 23.94 -13.31
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..